S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT00096031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

NETWORK

Sponsor class

Conditions

Esophageal Cancer

Interventions

BIOLOGICAL: cetuximab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]